Literature DB >> 22348807

A new AQP1 null allele identified in a Gypsy woman who developed an anti-CO3 during her first pregnancy.

C Saison1, T Peyrard, C Landre, B A Ballif, K A Schlosser, I Dettori, C Chicheportiche, P Nemeth, J-P Cartron, L Arnaud.   

Abstract

BACKGROUND AND OBJECTIVES: The Colton blood group antigens are carried by the AQP1 water channel. AQP1(-/-) individuals, also known as Colton-null since they express no Colton antigens, do not suffer any apparent clinical consequence but may develop a clinically significant alloantibody (anti-CO3) induced by transfusion or pregnancy. Identification and transfusion support of Colton-null patients are highly challenging, not only due to the extreme rarity of this phenotype, the lack of appropriate reagents in most laboratories, as well as the possibility of confusing it with the recently described CO:-1,-2,3,-4 phenotype where AQP1 is present. This study investigated a new Colton-null case and evaluated three commercially available anti-AQP1s to identify Colton-null red blood cell samples.
METHODS: The Colton-null phenotype was investigated by standard serological techniques, AQP1 sequencing, immunoblot and flow cytometry analyses.
RESULTS: We identified and characterized the Colton-null phenotype in a Gypsy woman who developed an anti-CO3 during her first pregnancy. After developing a simple and robust method to sequence AQP1, we showed that she was apparently homozygous for a new AQP1 null allele, AQP1 601delG, whose product is not expressed in her red blood cells. We also established the Colton specificity of three commercially available anti-AQP1s in immunoblot and/or flow cytometry analyses.
CONCLUSION: This Gypsy woman represents the sixth Colton-null case characterized at the serological, genetic and biochemical levels. The validation here of new reagents and methods should facilitate the identification of Colton-null individuals.
© 2012 The Author(s). Vox Sanguinis © 2012 International Society of Blood Transfusion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22348807      PMCID: PMC4201376          DOI: 10.1111/j.1423-0410.2012.01590.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  18 in total

1.  Defective urinary concentrating ability due to a complete deficiency of aquaporin-1.

Authors:  L S King; M Choi; P C Fernandez; J P Cartron; P Agre
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

2.  The Colton blood groups in monosomy 7 of the bone marrow.

Authors:  A De la Chapelle; P Vuopio; R Sanger; P Teesdale
Journal:  Birth Defects Orig Artic Ser       Date:  1976

3.  Mutations in aquaporin-1 in phenotypically normal humans without functional CHIP water channels.

Authors:  G M Preston; B L Smith; M L Zeidel; J J Moulds; P Agre
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

4.  Pathogenetic significance of "pure" monosomy 7 in myeloproliferative disorders. Analysis of 14 cases.

Authors:  F Pasquali; P Bernasconi; R Casalone; M Fraccaro; C Bernasconi; M Lazzarino; E Morra; E P Alessandrino; M A Marchi; R Sanger
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

5.  Decreased pulmonary vascular permeability in aquaporin-1-null humans.

Authors:  Landon S King; Søren Nielsen; Peter Agre; Robert H Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

6.  Anti-Co3 and severe hemolytic disease of the newborn.

Authors:  C Savona-Ventura; E S Grech; A Zieba
Journal:  Obstet Gynecol       Date:  1989-05       Impact factor: 7.661

7.  Development and characterisation of a monoclonal antibody family against aquaporin 1 (AQP1) and aquaporin 4 (AQP4).

Authors:  Gergely Nagy; György Szekeres; Krisztián Kvell; Tímea Berki; Péter Németh
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

8.  Studies on the blood of a Co (a-b-) proposita and her family.

Authors:  P A Lacey; J Robinson; M L Collins; D G Bailey; C C Evans; J J Moulds; G L Daniels
Journal:  Transfusion       Date:  1987 May-Jun       Impact factor: 3.157

9.  A novel form of congenital dyserythropoietic anemia associated with deficiency of erythroid CD44 and a unique blood group phenotype [In(a-b-), Co(a-b-)].

Authors:  S F Parsons; J Jones; D J Anstee; P A Judson; B Gardner; E Wiener; J Poole; N Illum; S N Wickramasinghe
Journal:  Blood       Date:  1994-02-01       Impact factor: 22.113

10.  A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia.

Authors:  Lionel Arnaud; Carole Saison; Virginie Helias; Nicole Lucien; Dominique Steschenko; Marie-Catherine Giarratana; Claude Prehu; Bernard Foliguet; Lory Montout; Alexandre G de Brevern; Alain Francina; Pierre Ripoche; Odile Fenneteau; Lydie Da Costa; Thierry Peyrard; Gail Coghlan; Niels Illum; Henrik Birgens; Hannah Tamary; Achille Iolascon; Jean Delaunay; Gil Tchernia; Jean-Pierre Cartron
Journal:  Am J Hum Genet       Date:  2010-11-04       Impact factor: 11.025

View more
  3 in total

1.  The AQP1 del601G mutation in different European Romani (Gypsy) populations.

Authors:  Brigitte K Flesch; Bharti Morar; David Comas; Eduardo Muñiz-Diaz; Núria Nogués; Luba Kalaydjieva
Journal:  Blood Transfus       Date:  2016-05-11       Impact factor: 3.443

2.  The AQP1 mutation c.601delG causes the Co-negative phenotype in four patients belonging to the Romani (Gypsy) ethnic group.

Authors:  Brigitte K Flesch; Burkhard Just; Robert Deitenbeck; Angelika Reil; Jürgen Bux; Núria Nogués; Eduardo Muñiz-Diaz
Journal:  Blood Transfus       Date:  2013-10-18       Impact factor: 3.443

3.  Energetic and molecular water permeation mechanisms of the human red blood cell urea transporter B.

Authors:  Slim Azouzi; Marc Gueroult; Pierre Ripoche; Sandrine Genetet; Yves Colin Aronovicz; Caroline Le Van Kim; Catherine Etchebest; Isabelle Mouro-Chanteloup
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.